Priority Date: 28.05.09 (US 20090181756P)

Substituted aminopropionic derivatives as neprilysin inhibitors

  • Application ID: EP13151795
  • Status: PATENT GRANTED

Applicant

Technology company logo small
Technology Company

Attorneys

no operation time available
1 office
Technology Company
no operation time available
1 office
Technology Company

Specialization

This EP application has the IPC combination A61 (MEDICAL OR VETERINARY SCIENCE; HYGIENE) and C07 (ORGANIC CHEMISTRY). Novartis Pharma AG is specialized in the combination A61 and C07. We found, that TransMIT GmbH, Kailuweit & Uhlemann, Lederer Keller Patentanwälte Partnerschaft mbB, Vossius & Partner Patentanwälte Rechtsanwälte mbB, df-mp Dörries Frank-Molnia & Pohlman, Patentanwälte Rechtsanwälte PartG mbB and 221 others are specialized in all of these IPC classes as well. For a similar patent, they might be a good choice.

Timeline

  • 28.05.2009 - Priority Date (US 20090181756P)
  • 22.05.2013 - Publication A1 (EP2594557)
  • 10.08.2016 - Publication B1 (EP2594557)